Company News
MORE
![[제19회 대한민국 안전대상 - 국무총리상] 삼성바이오로직스](/upload/press/aec39cf378fc4132aed52894ac28bbdf.jpg)
Science & Technology
MORE
Social Media
YouTube
세계 최대 "Super Plant" 4공장 증설 계획 발표
닫기
세계 최대 "Super Plant" 4공장 증설 계획 발표
Due to uncertainties in the global economy and the risks associated with aging in-house facilities, outsourcing is increasingly becoming more popular for global pharmaceutical companies, who want to get their drug products to market faster. To meet the rising demand, #SamsungBiologics announced a Plant 4 expansion that will provide a multi-scale manufacturing production for our existing and future clients' needs. Named the "Super Plant", our fourth plant will be the world's largest single plant offering a 256K-liter capacity and a one-stop service capacity at a single site with top-notch quality and production efficiency—using Samsung Biologics’ cutting-edge plant design technology.
Samsung Biologics | Better Future for Hum...
Samsung Biologics, we envision building a better...
닫기
Samsung Biologics | Better Future for Hum...
At Samsung Biologics, our innovation starts with the best People, specifically “Pi Type” people who are not only rooted in more than one field of expertise, but also with the ability to span their influence across the organization. We invest in our People to develop Talent and demonstrate our core Values. We believe that attaining Knowledge builds Expertise, and combined with Creativity and strong Teamwork, we can achieve consistent ution of our mission, all the while living our core values of Humanity, Integrity, Passion, Ownership and Dedication to each other, our clients, and to society. Our People innovation is also the foundation upon which our other core innovation principles are built. Process Innovation is how we ensure the highest quality by striving beyond “good” to “best” manufacturing practices through client-centric innovation. Our ution excellence is enhanced by our agility, adaptability, and speed in responding to changing global business conditions, resulting in cost competitiveness for the benefit of our clients and for patient access to life saving drugs. Portfolio Innovation drives us to continuously expand our business scope and breadth of services beyond CMO to CDO and CRO, establishing global reach and proximity to our clients to offer fully integrated end-to-end services across an ever expanding diversified business portfolio, resulting in a highly maximized, “Super Value” for our shareholders and clients. The ultimate purpose of our People, Process, and Portfolio Innovation is to support our Clients and become their most trusted partner in the mission to improving human lives through biomedicines. We call this concept our “3P Innovation Chain” which is embedded in our business DNA – By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our Clients in achieving Better Life for humanity through biomedicines. Choosing Samsung means choosing better. Better life-giving biologics for "Better Life." Better Life with Samsung Biologics.
삼성바이오로직스, 최고의 CDMO 파트너
Interns play an integral role at Samsung Biologics-they...
닫기
삼성바이오로직스, 최고의 CDMO 파트너
As your most reliable and flexible CDMO partner, Samsung Biologics provides service offerings tailored to client and industry needs. In our enhanced & extended line of service, we leverage our business and sales efforts on small scale manufacturing and Asceptic filling in response to increasing demand. To find out more in detail, visit our website at www.samsungbiologics.com and get in touch.
